mortality/aging
• no pups survive more than 2 weeks
• mice treated with benserazide-levodopa show improvement in survival up to one month
|
• about 50% die between E11.5 to E15.5
|
growth/size/body
• body weight is lower on P7
|
• growth retardation is seen after birth in live-born pups
|
• poor weight gain is seen after birth in live-born pups
|
behavior/neurological
• mice perform worse and fall earlier than wild-type mice in the hindlimb suspension test
|
• P7 mice need more time to return to the prone position in the righting reflex test
|
• hindlimb clasping is seen when hung by the tail
|
• pups exhibit abnormal walking posture
|
• pups call significantly less than wild-type mice when separated from mothers and the average duration per call is shorter
|
nervous system
• tetrahydrobiopterin levels are decreased in the brain
|
homeostasis/metabolism
• accumulation of phenylalanine in the liver and brain, which is more severe in the brain
|
• dopamine is reduced in the brain at P7
• dopamine metabolites dihydroxyphenylacetic acid (DOPAC), 3-methoxytyramine (3-MT), and homovanillic acid (HVA) are reduced in the brain at P7
|
• norepinephrine is reduced in the brain
|
• serotonin is reduced in the brain
|
• tyrosine hydroxylase is undetectable in the striatum
|
liver/biliary system
• tetrahydrobiopterin levels are decreased in the liver
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
BH4-deficient hyperphenylalaninemia B | DOID:0112225 |
OMIM:233910 |
J:295169 |